Matthew Gline
Chief Executive Officer chez ROIVANT SCIENCES LTD.
Fortune : 12 M $ au 31/03/2024
Profil
Actuellement, Matthew Gline occupe le poste de directeur général et de directeur chez Roivant Sciences Ltd. et de directeur général de Roivant Sciences GmbH et de directeur général de Roivant Sciences, Inc. (toutes deux sont des filiales de Roivant Sciences Ltd.). Il est également membre du conseil d'administration de Sumitovant Biopharma, Inc. Dans sa carrière antérieure, M. Gline a été directeur général et administrateur de Montes Archimedes Acquisition Corp. Matthew Gline a obtenu un diplôme de premier cycle au Harvard College.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
ROIVANT SCIENCES LTD.
0,14% | 20/04/2024 | 1 153 706 ( 0,14% ) | 12 M $ | 31/03/2024 |
Postes actifs de Matthew Gline
| Sociétés | Poste | Début |
|---|---|---|
| ROIVANT SCIENCES LTD. | Chief Executive Officer | 01/01/2021 |
Sumitovant Biopharma, Inc.
 Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Director/Board Member | - |
Roivant Sciences GmbH
 Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Chief Executive Officer | 01/01/2021 |
Roivant Sciences, Inc.
 Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Chief Executive Officer | 01/01/2021 |
| Roivant Social Ventures, Inc. | Director/Board Member | 01/03/2016 |
Anciens postes connus de Matthew Gline
| Sociétés | Poste | Fin |
|---|---|---|
| ROIVANT SCIENCES LTD. | Chief Executive Officer | - |
| UROVANT SCIENCES LTD. | Director/Board Member | - |
Formation de Matthew Gline
| Harvard College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| ROIVANT SCIENCES LTD. | Health Technology |
| Entreprise privées | 6 |
|---|---|
Roivant Sciences GmbH
Roivant Sciences GmbH Pharmaceuticals: MajorHealth Technology Roivant Sciences GmbH engages in the development and marketing of biopharmaceutical products. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in Basel, Switzerland. | Health Technology |
Roivant Sciences, Inc.
Roivant Sciences, Inc. Pharmaceuticals: MajorHealth Technology Roivant Sciences, Inc. operates as a pharmaceutical firm. It develops and markets drugs. The firm specializes in uterine fibroids, endometriosis, prostate cancer, diabetes, and pulmonary arterial hypertension. The company was founded by Vivek Ramaswamy in 2014 and is headquartered in New York, NY. | Health Technology |
Urovant Sciences Ltd.
 Urovant Sciences Ltd. Pharmaceuticals: MajorHealth Technology Urovant Sciences Ltd. is a clinical-stage biopharmaceutical company, which through its subsidiaries, engages in the development and commercialization of therapies for urologic conditions. Its pipeline includes Vibegron (RVT-901) and URO-902. The company was founded on January 27, 2016 and is headquartered in London, the United Kingdom. | Health Technology |
Sumitovant Biopharma, Inc.
Sumitovant Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Sumitovant Biopharma, Inc. provides biotechnology services. It offers oncology, gene therapy, rare, pulmonary, urological disease, digital innovation and novel platforms. The company is headquartered in New York, NY. | Health Technology |
Montes Archimedes Acquisition Corp.
 Montes Archimedes Acquisition Corp. Financial ConglomeratesFinance Montes Archimedes Acquisition Corp operates as a blank check company. It is formed for the business purpose to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company was founded James C. Momtazee and Maria C. Walker on July 6, 2020 and is headquartered in Menlo Park, CA. | Finance |
| Roivant Social Ventures, Inc. |
